Article Information
History
- July 18, 2020.
Article Versions
- Version 1 (July 18, 2020 - 00:41).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Thamir M. Alshammari1,2,*,
- Khalidah A. Alenzi3,
- Fatemah A Alnofal2,
- Ghada Fradees4 and
- Ali F. Altebainawi1,6
- 1Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia
- 2Saudi Food and Drug Authority, Riyadh, Saudi Arabia
- 3Regional Drug Information and Pharmacovigilance Center, Ministry of Health, Tabuk, Saudi Arabia
- 4Pharmaceutical Care Services, Prince Sultan Cardiac Center, Ministry of Health, Alqassim, Saudi Arabia
- 5Pharmaceutical Care Services, Ministry of Health, Riyadh, Saudi Arabia
- 6Pharmaceutical Care Services, King Khalid Hospital, Ministry of Health, Hail, Saudi Arabia
- ↵*Corresponding Author:
Thamir M. Alshammari, RPh, Ph.D, M.S, Advisor, Saudi Food and Drug Authority Executive President, Associate Professor of Pharmacy Practice, Senior researcher, Medication Safety Research Chair, King Saud University, Vice-President, International Society of Pharmacovigilance Middle East, Pharmacoepidemiology and Pharmacovigilance Consultant, Riyadh, Saudi Arabia, Phone: +966505192886, Email: thamer.alshammary{at}gmail.com